Accreditation Canada’s Post

Uveitic glaucoma patients are closer than ever to having a potent anti-inflammatory drug with none of the side effects that come along with the use of steroids. Tarsier Pharma is going beyond steroids to change lives for the better.

How radical is your thinking when it comes to Longevity?

This is, in essence, why I chose to work in Inpeco: to help healthcare professionals like Benoit in their efforts to streamline their work, to get better data faster, and by extension to do our small part in having better healthcare for everyone!

Have you seen Joshua L. Robinson at HFMA Colorado Chapter's Spring Symposium? This event features a panel of Revenue Cycle Leaders discussing goals and challenges within their organizations and the healthcare landscape. If you would like to learn more about Signature Performance, Inc. and our capabilities, keep an eye out for Josh today and tomorrow. If you're not in attendance, you can learn more here: https://lnkd.in/gBdT7Van #RevenueCycle #HealthcareAdministration #Symposium #HFMA #HealthcareLeaders

Read the first post from the president by Kevin Gutsell

From the robust direction by our former MD and CEO Ittira Davis to the bright future being heralded by our new MD and CEO Sanjeev Nautiyal, read all about it in the article here- https://lnkd.in/gVDcieED

This past Wednesday, our President and Chief Executive Officer took the stage at HLTH USA to open the #GLP1 Summit and provide his perspective on the landscape of #cardiometabolic disease management. Key takeaways: 1️⃣ Despite spending nearly 2X more on healthcare than peer countries, the health status of Americans is deteriorating. From 2020 to 2050, the percentage of U.S. adults with chronic conditions is projected to increase by 12.4 percentage points.  2️⃣ Between 2020 and 2022, prescription volumes for GLP-1 medications increased 300%, and in 2021, national spending on #semaglutide (the peptide name for drugs like #Ozempic and #Wegovy) totaled $10.7B. 3️⃣ The increase in GLP-1 use does not correlate with clinical indication. Just over half of patients taking GLP-1s have a history of type 2 diabetes or have an associated medical visit with their prescription. Explore more research on GLP-1s and metabolic health: https://lnkd.in/eGKQsQSs #bebold #healthcare #healthinnovation #futureofhealth #HLTH 

Although there are many reasons to attend the APTA Private Practice Annual Conference, we managed to narrow it down to five of these top reasons. If you've attended one of our conferences in the past, let us know if there's something you would add to this list!

Taking discoveries down the deployment track requires an unbreakable human chain linking all of the skills necessary for the journey. The strength of that chain is not however is not just in the diversity of skills it is in how they are integrated through a collegial and collaborative approach that engenders trust in each other. Translation through connectivity ! I will share some thoughts on how this might be achieved in the modern era of research.

Did you know? North Suburban has once again been recognized by the Lown Institute as one of the most socially responsible hospitals in America, receiving "A" grades in Equity, Value and Outcomes on the 2024-25 Lown Institute Hospitals Index? Out of more than 3,500 hospitals measured by Lown, only 5% achieved honor roll status, with North Suburban ranking among this select group of high performers. Learn more at https://lnkd.in/gMp7Z8is.